Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
Briskman I, Bar G, Boaz M, Shargorodsky M. Briskman I, et al. Among authors: bar g. Int J Psychiatry Med. 2012;43(4):339-48. doi: 10.2190/PM.43.4.d. Int J Psychiatry Med. 2012. PMID: 23094466
Deliberate Self-Harm in Older Adults: A General Hospital Emergency Department Survey.
Briskman I, Shelef A, Berger U, Baruch Y, Bar G, Asherov J, Lvovski A, Apter A, Barak Y. Briskman I, et al. Among authors: bar g. Isr Med Assoc J. 2017 Mar;19(3):160-163. Isr Med Assoc J. 2017. PMID: 28457093 Free article.
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial.
Yovell Y, Bar G, Mashiah M, Baruch Y, Briskman I, Asherov J, Lotan A, Rigbi A, Panksepp J. Yovell Y, et al. Among authors: bar g. Am J Psychiatry. 2016 May 1;173(5):491-8. doi: 10.1176/appi.ajp.2015.15040535. Epub 2015 Dec 18. Am J Psychiatry. 2016. PMID: 26684923 Clinical Trial.
Ultra-Low-Dose Buprenorphine for Mental Pain: Response to Ruan et al.
Yovell Y, Bar G. Yovell Y, et al. Among authors: bar g. Am J Psychiatry. 2016 Oct 1;173(10):1043-1044. doi: 10.1176/appi.ajp.2016.16050512r. Am J Psychiatry. 2016. PMID: 27690553 No abstract available.
Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.
Kremer I, Vass A, Gorelik I, Bar G, Blanaru M, Javitt DC, Heresco-Levy U. Kremer I, et al. Among authors: bar g. Biol Psychiatry. 2004 Sep 15;56(6):441-6. doi: 10.1016/j.biopsych.2004.06.029. Biol Psychiatry. 2004. PMID: 15364042 Clinical Trial.
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.
Heresco-Levy U, Ermilov M, Lichtenberg P, Bar G, Javitt DC. Heresco-Levy U, et al. Among authors: bar g. Biol Psychiatry. 2004 Jan 15;55(2):165-71. doi: 10.1016/s0006-3223(03)00707-8. Biol Psychiatry. 2004. PMID: 14732596 Clinical Trial.
Characteristics of schizophrenia residents and staff rejection in community mental health hostels.
Levy E, Shefler G, Loewenthal U, Umansky R, Bar G, Heresco-Levy U. Levy E, et al. Among authors: bar g. Isr J Psychiatry Relat Sci. 2005;42(1):23-32. Isr J Psychiatry Relat Sci. 2005. PMID: 16134404
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.
Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M. Heresco-Levy U, et al. Among authors: bar g. Biol Psychiatry. 2005 Mar 15;57(6):577-85. doi: 10.1016/j.biopsych.2004.12.037. Biol Psychiatry. 2005. PMID: 15780844 Clinical Trial.
Reduced prepulse inhibition is associated with increased hypnotizability.
Lichtenberg P, Even-Or E, Bar G, Levin R, Brin A, Heresco-Levy U. Lichtenberg P, et al. Among authors: bar g. Int J Neuropsychopharmacol. 2008 Jun;11(4):541-5. doi: 10.1017/S1461145707008231. Epub 2007 Nov 30. Int J Neuropsychopharmacol. 2008. PMID: 18047757
High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients.
Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC. Heresco-Levy U, et al. Among authors: bar g. Schizophr Res. 2007 Mar;91(1-3):14-21. doi: 10.1016/j.schres.2006.12.003. Epub 2007 Feb 2. Schizophr Res. 2007. PMID: 17276036
58 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback